{"id":"https://openalex.org/W2587592231","doi":"https://doi.org/10.1182/blood.v128.22.114.114","title":"Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study","display_name":"Successful Emulation of IV Decitabine Pharmacokinetics with an Oral Fixed-Dose Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine, in Subjects with Myelodysplastic Syndromes (MDS): Final Data of Phase 1 Study","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2587592231","doi":"https://doi.org/10.1182/blood.v128.22.114.114","mag":"2587592231"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.114.114","doi":"https://doi.org/10.1182/blood.v128.22.114.114","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.114.114","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060015628","display_name":"Olatoyosi M. Odenike","orcid":"https://orcid.org/0000-0002-4027-4124","observed_orcids":["https://orcid.org/0000-0002-4027-4124"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olatoyosi Odenike","raw_affiliation_strings":["University of Chicago, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009091754","display_name":"Philip C. Amrein","orcid":"https://orcid.org/0000-0001-7770-2623","observed_orcids":["https://orcid.org/0000-0001-7770-2623"]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Philip C. Amrein","raw_affiliation_strings":["Massachusetts General Hospital, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital, Boston, MA","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090527595","display_name":"David P. Steensma","orcid":"https://orcid.org/0000-0001-5130-9284","observed_orcids":["https://orcid.org/0000-0001-5130-9284"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David P. Steensma","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035609080","display_name":"Amy Elizabeth Dezern","orcid":"https://orcid.org/0000-0001-5225-4609","observed_orcids":["https://orcid.org/0000-0001-5225-4609"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I4210150714","display_name":"Johns Hopkins Hospital","ror":"https://ror.org/05cb1k848","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436","https://openalex.org/I4210150714"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amy E. DeZern","raw_affiliation_strings":["Johns Hopkins University Hospital, Baltimore, MD"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johns Hopkins University Hospital, Baltimore, MD","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I4210150714"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022002706","display_name":"Laura Christian Michaelis","orcid":"https://orcid.org/0000-0002-1798-9658","observed_orcids":["https://orcid.org/0000-0002-1798-9658"]},"institutions":[{"id":"https://openalex.org/I204308271","display_name":"Medical College of Wisconsin","ror":"https://ror.org/00qqv6244","country_code":"US","type":"education","lineage":["https://openalex.org/I204308271"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laura C. Michaelis","raw_affiliation_strings":["Medical College of Wisconsin, Milwaukee, WI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical College of Wisconsin, Milwaukee, WI","institution_ids":["https://openalex.org/I204308271"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046097970","display_name":"Stefan H Faderl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324520350","display_name":"Hackensack University Medical Center","ror":"https://ror.org/008zj0x80","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1324520350"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stefan Faderl","raw_affiliation_strings":["Hackensack University Medical Center, Hackensack, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hackensack University Medical Center, Hackensack, NJ","institution_ids":["https://openalex.org/I1324520350"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008299243","display_name":"James N. Lowder","orcid":"https://orcid.org/0000-0003-4267-5447","observed_orcids":["https://orcid.org/0000-0003-4267-5447"]},"institutions":[{"id":"https://openalex.org/I4387155454","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"James N. Lowder","raw_affiliation_strings":["Astex Pharmaceuticals, Inc., Pleasanton, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astex Pharmaceuticals, Inc., Pleasanton, CA","institution_ids":["https://openalex.org/I4387155454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018689852","display_name":"Pietro Taverna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155454","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Pietro Taverna","raw_affiliation_strings":["Astex Pharmaceuticals, Inc., Pleasanton, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astex Pharmaceuticals, Inc., Pleasanton, CA","institution_ids":["https://openalex.org/I4387155454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001745177","display_name":"Aram Oganesian","orcid":"https://orcid.org/0000-0001-5358-743X","observed_orcids":["https://orcid.org/0000-0001-5358-743X"]},"institutions":[{"id":"https://openalex.org/I4387155454","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Aram Oganesian","raw_affiliation_strings":["Astex Pharmaceuticals, Inc., Pleasanton, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astex Pharmaceuticals, Inc., Pleasanton, CA","institution_ids":["https://openalex.org/I4387155454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100363169","display_name":"Xiaoping Zhang","orcid":"https://orcid.org/0000-0003-0995-4989","observed_orcids":["https://orcid.org/0000-0003-0995-4989","https://orcid.org/0000-0002-8687-3800"]},"institutions":[{"id":"https://openalex.org/I4387155454","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaoping Zhang","raw_affiliation_strings":["Astex Pharmaceuticals, Inc., Pleasanton, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astex Pharmaceuticals, Inc., Pleasanton, CA","institution_ids":["https://openalex.org/I4387155454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019816977","display_name":"Mohammad Azab","orcid":"https://orcid.org/0009-0001-8837-6613","observed_orcids":["https://orcid.org/0009-0001-8837-6613"]},"institutions":[{"id":"https://openalex.org/I4387155454","display_name":"Astex Pharmaceuticals","ror":"https://ror.org/05fx1fs38","country_code":"US","type":"company","lineage":["https://openalex.org/I114030911","https://openalex.org/I4387155454"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohammad Azab","raw_affiliation_strings":["Astex Pharmaceuticals, Inc., Pleasanton, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Astex Pharmaceuticals, Inc., Pleasanton, CA","institution_ids":["https://openalex.org/I4387155454"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I200719446","display_name":"Vanderbilt University","ror":"https://ror.org/02vm5rt34","country_code":"US","type":"education","lineage":["https://openalex.org/I200719446"]},{"id":"https://openalex.org/I4390039299","display_name":"Vanderbilt-Ingram Cancer Center","ror":"https://ror.org/02rjj2m04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I4390039299","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Savona","raw_affiliation_strings":["Vanderbilt-Ingram Cancer Center, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vanderbilt-Ingram Cancer Center, Nashville, TN","institution_ids":["https://openalex.org/I200719446","https://openalex.org/I4390039299"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5001745177","https://openalex.org/A5008299243","https://openalex.org/A5018689852","https://openalex.org/A5100363169"],"corresponding_institution_ids":["https://openalex.org/I4387155454"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":3.7979,"has_fulltext":false,"cited_by_count":16,"citation_normalized_percentile":{"value":0.93551877,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"128","issue":"22","first_page":"114","last_page":"114"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.8086000084877014,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10269","display_name":"Epigenetics and DNA Methylation","score":0.024399999529123306,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.01590000092983246,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/decitabine","display_name":"decitabine","score":0.8880000114440918},{"id":"https://openalex.org/keywords/astx727","display_name":"ASTX727","score":0.9829999804496765},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9160000085830688},{"id":"https://openalex.org/keywords/chronic-myelomonocytic-leukemia","display_name":"chronic myelomonocytic leukemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hypomethylating-agents","display_name":"hypomethylating agents","score":0.9549999833106995},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8069999814033508},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7540000081062317},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6650000214576721},{"id":"https://openalex.org/keywords/line-1-methylation","display_name":"LINE-1 methylation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.5329999923706055},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.46000000834465027}],"concepts":[{"id":"https://openalex.org/C2780235182","wikidata":"https://www.wikidata.org/wiki/Q1181878","display_name":"Decitabine","level":5,"score":0.8532845973968506},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8283225297927856},{"id":"https://openalex.org/C2780240888","wikidata":"https://www.wikidata.org/wiki/Q6052586","display_name":"International Prognostic Scoring System","level":4,"score":0.631606936454773},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6085536479949951},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.5974732637405396},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5629549622535706},{"id":"https://openalex.org/C2777928532","wikidata":"https://www.wikidata.org/wiki/Q1088072","display_name":"Chronic myelomonocytic leukemia","level":4,"score":0.5571178197860718},{"id":"https://openalex.org/C2776239401","wikidata":"https://www.wikidata.org/wiki/Q416451","display_name":"Azacitidine","level":5,"score":0.5174915790557861},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4957791268825531},{"id":"https://openalex.org/C2776985229","wikidata":"https://www.wikidata.org/wiki/Q18021211","display_name":"Cytidine deaminase","level":3,"score":0.4923487901687622},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.4469451606273651},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.43814677000045776},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.43437811732292175},{"id":"https://openalex.org/C2780873365","wikidata":"https://www.wikidata.org/wiki/Q496812","display_name":"Leukopenia","level":3,"score":0.4136947989463806},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.38629987835884094},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3764292597770691},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2277265191078186},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08776560425758362},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.08014687895774841},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C190727270","wikidata":"https://www.wikidata.org/wiki/Q874745","display_name":"DNA methylation","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.114.114","doi":"https://doi.org/10.1182/blood.v128.22.114.114","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.114.114","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2979947481","https://openalex.org/W3123807920","https://openalex.org/W2986575254","https://openalex.org/W606465697","https://openalex.org/W4389234373","https://openalex.org/W3096384900","https://openalex.org/W4240861063","https://openalex.org/W2923645205","https://openalex.org/W4283315732","https://openalex.org/W4389247626"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[1],"Patients":[2],"with":[3,22,97,141,231,467,507,679,700],"International":[4,294],"Prognostic":[5],"Scoring":[6],"System":[7],"(IPSS)":[8],"intermediate":[9],"1":[10,114,212,419,440,503],"and":[11,14,28,56,88,136,261,337,451,464,518,553,586,613,631,645,661,694,750,763],"2":[12,728],"(Int)":[13],"high":[15],"risk":[16],"(HR)":[17],"MDS":[18,145,762],"benefit":[19],"from":[20,340,412,528],"therapy":[21],"hypomethylating":[23],"agents":[24],"(HMAs)":[25],"decitabine":[26],"(DAC)":[27],"azacitidine":[29],"(AZA).":[30],"Treatment":[31],"requires":[32],"5":[33,311,535,602,624,632,710,738,756],"or":[34,143,146,269,760,780,792,804,816,828,840,892,904,922,936,947],"7":[35],"daily":[36,191,736,754],"parenteral":[37],"doses":[38,263,431,745],"every":[39],"month":[40],"while":[41],"the":[42,86,108,161,164,166,189,197,238,293,524,577,667,744],"patient":[43,54,201,320,542],"is":[44,70,94],"benefitting.":[45],"An":[46],"oral":[47,74,134,179,219,232,262,474,489,525,741],"HMA":[48,718],"taken":[49],"at":[50,188,237,253,425,435,448,456,480,743],"home":[51],"would":[52],"provide":[53],"convenience,":[55],"potentially":[57],"enhance":[58],"adherence":[59],"to":[60,77,159,171,182,352,414,420,428,441,445,453,530,576,724,740],"treatment":[61],"particularly":[62],"for":[63,267,299,365,383,709,737,755],"long-term":[64],"responders.":[65],"Neither":[66],"DAC":[67,135,177,187,205,367,385,430,470,485,516,526,662,674,705,732,749],"nor":[68],"AZA":[69],"readily":[71],"bioavailable":[72,96],"in":[73,85,102,124,153,248,258,286,310,370,405,417,438,462,494,533,538,543,563,688,758],"form":[75],"due":[76],"rapid":[78],"clearance":[79],"by":[80,185,218,225,282,482,512],"cytidine":[81],"deaminase":[82],"(CDA)":[83],"present":[84],"gut":[87],"liver.":[89],"E7727,":[90],"a":[91,98,112,121,173,254,318,375,389,547,680,725],"novel":[92],"CDAi,":[93],"orally":[95],"large":[99],"safety":[100,162,682],"margin":[101],"preclinical":[103],"models.":[104],"We":[105],"report":[106],"here":[107],"final":[109],"results":[110],"of":[111,120,129,133,163,176,193,207,241,313,322,378,392,396,399,551,574,601,646,659,671,746,778,790,802,814,826,838,890,902,920,934,945],"Phase":[113],"study":[115,729],"including":[116,356,623],"an":[117,203,214,775,787,799,811,823,835,887,899,917,931,942],"extension":[118],"arm":[119],"PK-guided":[122],"first":[123,198,411],"human":[125],"dose":[126,192,206,240,274,508,527,548],"escalation":[127,275,509],"trial":[128],"ASTX727":[130,180,220,233,400,475,490,656,720,742],"(the":[131,657],"combination":[132,658],"E7727).":[137],"Methods:":[138],"Adult":[139],"patients":[140,307,315,355,372,609,637],"Int":[142,759],"HR":[144,761],"Chronic":[147],"Myelomonocytic":[148],"Leukemia":[149],"(CMML)":[150],"were":[151,229,245,264,280,290,308,335,401,432,520,561,579,597,606,649],"enrolled":[152],"this":[154],"dose-escalating":[155],"trial.":[156],"In":[157,196],"addition":[158],"assessing":[160],"combination,":[165],"primary":[167,668],"PK":[168,669],"objective":[169,618,670],"was":[170,256,276,328,342,409],"achieve":[172],"mean":[174,376,390],"AUC":[175,364,463,471,517,677],"following":[178,704],"comparable":[181],"that":[183],"achieved":[184,666],"IV":[186,204,366,384,479,493,673,708,731,735],"approved":[190],"20":[194,208,357,368,386,436,675,706,733],"mg/m2.":[195],"cycle,":[199],"each":[200,259,316,397],"received":[202,360,716],"mg/m2":[209,369,387,676,707,734],"on":[210,221,234,501,611,774,786,798,810,822,834,886,898,916,930,941],"Day":[211,504,684],"as":[213,403,536],"internal":[215],"comparator":[216],"followed":[217],"Days":[222,235],"2-5":[223],"escalated":[224,257,402,410,444],"cohort.":[226],"Subsequent":[227],"cycles":[228,603],"given":[230],"1-5":[236],"same":[239],"Cycle":[242],"1.":[243,407,540],"Cycles":[244],"28":[246],"days":[247,344,739,757],"length.":[249],"Only":[250],"one":[251],"component":[252,398],"time":[255,339],"cohort":[260,323,449,457,483,513,534,544],"not":[265],"adjusted":[266],"weight":[268],"body":[270],"surface":[271],"area.":[272],"Intrapatient":[273],"permitted.":[277],"Pharmacodynamics":[278],"(PD)":[279],"evaluated":[281],"LINE-1":[283,499,686],"DNA":[284],"methylation":[285],"peripheral":[287],"blood.":[288],"Responses":[289],"assessed":[291],"using":[292],"Working":[295],"Group":[296],"(IWG)":[297],"criteria":[298],"response":[300,693],"(Cheson":[301],"et":[302],"al,":[303],"2006).":[304],"Results:":[305],"43":[306],"treated":[309],"cohorts":[312,418,426,439],"6":[314,641,647],"plus":[317],"13":[319],"expansion":[321],"5.":[324,458],"The":[325,363,381,566],"median":[326,338,600],"age":[327],"71.5":[329],"years":[330],"(range":[331,345,604],"59-86),":[332],"30/43":[333],"(70%)":[334],"male,":[336],"diagnosis":[341],"273":[343],"5-3518).":[346],"Prior":[347],"therapies":[348],"had":[349,359,374,388,546,715],"been":[350],"administered":[351,663],"22/43":[353],"(51%)":[354],"who":[358,648],"prior":[361,717],"HMA.":[362],"all":[371],"(n=43)":[373],"(CV)":[377,391],"171(37%)":[379],"ng*hr/mL.":[380],"Cmax":[382,465,486,519],"179(36%)":[393],"ng/mL.":[394],"Doses":[395],"shown":[404,537],"Table":[406,539],"E7727":[408,660,753],"40":[413,446,529],"100":[415,751],"mg":[416,437,447,455,532,748,752],"3":[421,442,557,571,594],"then":[422,443,477],"kept":[423,433],"constant":[424,434],"4":[427,450,545,628],"6.":[429],"de-escalated":[452],"30":[454,531],"Dose":[459],"dependent":[460],"increases":[461],"occurred":[466],"escalating":[468],"doses.":[469],"values":[472,487],"after":[473,488,522],"approached":[476],"exceeded":[478,492],"149%":[481],"4.":[484,514],"never":[491],"any":[495,564],"Cohort.":[496],"Mean":[497],"%":[498],"demethylation":[500,687],"cycle":[502],"8\u00b1SE":[505],"increased":[506],"reaching":[510],"12.8%\u00b13.8":[511],"Lower":[515],"observed":[521,562],"lowering":[523],"One":[541],"limiting":[549],"toxicity":[550],"thrombocytopenia":[552,580],"no":[554],"Grade":[555,570,592],"\u2265":[556,569,593],"drug-related":[558,591],"non-hematologic":[559],"AEs":[560,572,596],"patient.":[565],"most":[567],"common":[568],"regardless":[573],"relationship":[575],"drug":[578],"(36%),":[581],"anemia":[582],"(30%),":[583],"neutropenia":[584,588],"(27%),":[585],"febrile":[587],"(21%).":[589],"No":[590],"gastrointestinal":[595],"reported.":[598],"A":[599],"1-23)":[605],"administered,":[607],"11":[608],"remain":[610],"therapy,":[612],"14":[614],"(32%)":[615],"have":[616],"experienced":[617],"clinical":[619,692],"responses":[620],"so":[621],"far,":[622],"Complete":[625],"Response":[626],"(CR),":[627],"marrow":[629],"CR,":[630],"Hematologic":[633],"Improvement.":[634],"Of":[635],"23":[636],"initially":[638],"RBC":[639],"dependent,":[640,651],"(26%),":[642],"became":[643,653],"independent":[644],"platelet":[650],"2(33%)":[652],"independent.":[654],"Conclusions:":[655],"PO":[664],"concomitantly)":[665],"emulating":[672],"levels":[678],"similar":[681],"profile.":[683],"8":[685],"Cohort":[689],"4,":[690],"overall":[691],"transfusion":[695],"independence":[696],"rates":[697],"are":[698],"consistent":[699],"those":[701],"historically":[702],"reported":[703],"days,":[711],"even":[712],"though":[713],"47%":[714],"therapy.":[719],"has":[721],"now":[722],"proceeded":[723],"randomized":[726],"phase":[727],"comparing":[730],"35":[747],"CMML":[764],"patients.":[765],"Disclosures":[766],"Odenike:":[767],"Geron:":[768],"Research":[769,909,912,926,950],"Funding;":[770,910,913,927],"Suneisis:":[771],"Honoraria,":[772,784,796,808,820,832,862],"Membership":[773,785,797,809,821,833,885,897,915,929,940],"entity's":[776,788,800,812,824,836,888,900,918,932,943],"Board":[777,789,801,813,825,837,889,901,919,933,944],"Directors":[779,791,803,815,827,839,891,903,921,935,946],"advisory":[781,793,805,817,829,841,893,905,923,937,948],"committees;":[782,794,806,818,830,894,906,924,938],"Incyte:":[783,939],"CTI/Baxter:":[795],"Sanofi-Aventis:":[807],"Spectrum:":[819],"Algeta:":[831],"committees.":[842],"Steensma:Amgen:":[843],"Consultancy;":[844,846,848,853],"Celgene:":[845,861,914],"Janssen:":[847],"Ariad:":[849],"Equity":[850,859],"Ownership;":[851,860],"Genoptix:":[852],"Millenium/Takeda:":[854],"Consultancy.":[855],"Michaelis:Incyte:":[856],"Honoraria;":[857],"Pfizer:":[858],"Speakers":[863],"Bureau.":[864],"Lowder:Astex":[865],"Pharmaceuticals,":[866,873,877,881],"Inc.:":[867,874,878,882,896],"Employment.":[868,871,875,879,883],"Taverna:Astex":[869],"Pharmaceuticals:":[870],"Oganesian:Astex":[872],"Zhang:Astex":[876],"Azab:Astex":[880],"Savona:Ariad:":[884],"Amgen":[895],"TG":[907],"Therapeutics:":[908],"Sunesis:":[911],"Takeda:":[925],"Gilead:":[928],"committees,":[949],"Funding.":[951]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2017-02-17T00:00:00"}